| abstract |
Nanoparticle drug conjugates (NDC) are described herein that include a non-toxic, multi-form, clinically proven, silica-based nanoparticle platform with covalently attached drug molecules / moieties in certain embodiments. Nanoparticle drug conjugates (NDC) exhibit imaging ability and targeting ligands that are effectively transparent across the kidneys. Also, the conjugate is incorporated with a therapeutic agent for the detection, prevention, and / or treatment of cancer. |